147 related articles for article (PubMed ID: 33755462)
1. Expedient Total Syntheses of Pladienolide-Derived Spliceosome Modulators.
Rhoades D; Rheingold AL; O'Malley BW; Wang J
J Am Chem Soc; 2021 Apr; 143(13):4915-4920. PubMed ID: 33755462
[TBL] [Abstract][Full Text] [Related]
2. Total Syntheses of Pladienolide-Derived Spliceosome Modulators.
Sim J; Jang E; Kim HJ; Jeon H
Molecules; 2021 Sep; 26(19):. PubMed ID: 34641481
[TBL] [Abstract][Full Text] [Related]
3. Enantioselective total synthesis of pladienolide B: a potent spliceosome inhibitor.
Ghosh AK; Anderson DD
Org Lett; 2012 Sep; 14(18):4730-3. PubMed ID: 22954141
[TBL] [Abstract][Full Text] [Related]
4. Enantioselective synthesis of pladienolide B and truncated analogues as new anticancer agents.
Kumar VP; Chandrasekhar S
Org Lett; 2013 Jul; 15(14):3610-3. PubMed ID: 23822896
[TBL] [Abstract][Full Text] [Related]
5. Total Synthesis of the Spliceosome Modulator Pladienolide B via Asymmetric Alcohol-Mediated syn- and anti-Diastereoselective Carbonyl Crotylation.
Yoo M; Krische MJ
Angew Chem Int Ed Engl; 2021 Jun; 60(25):13923-13928. PubMed ID: 33794050
[TBL] [Abstract][Full Text] [Related]
6. A synthetic entry to pladienolide B and FD-895.
Mandel AL; Jones BD; La Clair JJ; Burkart MD
Bioorg Med Chem Lett; 2007 Sep; 17(18):5159-64. PubMed ID: 17681759
[TBL] [Abstract][Full Text] [Related]
7. Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B.
Kashyap MK; Kumar D; Villa R; La Clair JJ; Benner C; Sasik R; Jones H; Ghia EM; Rassenti LZ; Kipps TJ; Burkart MD; Castro JE
Haematologica; 2015 Jul; 100(7):945-54. PubMed ID: 25862704
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of the macrocyclic core of (-)-pladienolide B.
Skaanderup PR; Jensen T
Org Lett; 2008 Jul; 10(13):2821-4. PubMed ID: 18510332
[TBL] [Abstract][Full Text] [Related]
9. Total synthesis of the potent antitumor macrolides pladienolide B and D.
Kanada RM; Itoh D; Nagai M; Niijima J; Asai N; Mizui Y; Abe S; Kotake Y
Angew Chem Int Ed Engl; 2007; 46(23):4350-5. PubMed ID: 17437311
[No Abstract] [Full Text] [Related]
10. Test-firing ammunition for spliceosome inhibition in cancer.
Dehm SM
Clin Cancer Res; 2013 Nov; 19(22):6064-6. PubMed ID: 24097858
[TBL] [Abstract][Full Text] [Related]
11. Potential effect of spliceosome inhibition in small cell lung cancer irrespective of the MYC status.
Suda K; Rozeboom L; Yu H; Ellison K; Rivard CJ; Mitsudomi T; Hirsch FR
PLoS One; 2017; 12(2):e0172209. PubMed ID: 28192473
[TBL] [Abstract][Full Text] [Related]
12. Antitumor compounds based on a natural product consensus pharmacophore.
Lagisetti C; Pourpak A; Jiang Q; Cui X; Goronga T; Morris SW; Webb TR
J Med Chem; 2008 Oct; 51(19):6220-4. PubMed ID: 18788726
[TBL] [Abstract][Full Text] [Related]
13. Pre-mRNA splicing-modulatory pharmacophores: the total synthesis of herboxidiene, a pladienolide-herboxidiene hybrid analog and related derivatives.
Lagisetti C; Yermolina MV; Sharma LK; Palacios G; Prigaro BJ; Webb TR
ACS Chem Biol; 2014 Mar; 9(3):643-8. PubMed ID: 24377313
[TBL] [Abstract][Full Text] [Related]
14. The cryo-EM structure of the SF3b spliceosome complex bound to a splicing modulator reveals a pre-mRNA substrate competitive mechanism of action.
Finci LI; Zhang X; Huang X; Zhou Q; Tsai J; Teng T; Agrawal A; Chan B; Irwin S; Karr C; Cook A; Zhu P; Reynolds D; Smith PG; Fekkes P; Buonamici S; Larsen NA
Genes Dev; 2018 Feb; 32(3-4):309-320. PubMed ID: 29491137
[TBL] [Abstract][Full Text] [Related]
15. The spliceosome inhibitors isoginkgetin and pladienolide B induce ATF3-dependent cell death.
Vanzyl EJ; Sayed H; Blackmore AB; Rick KRC; Fernando P; McKay BC
PLoS One; 2020; 15(12):e0224953. PubMed ID: 33370278
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric analysis identifies changes in S and M phases as novel cell cycle alterations induced by the splicing inhibitor isoginkgetin.
Vanzyl EJ; Rick KRC; Blackmore AB; MacFarlane EM; McKay BC
PLoS One; 2018; 13(1):e0191178. PubMed ID: 29338026
[TBL] [Abstract][Full Text] [Related]
17. Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors.
Ghosh AK; Mishevich JL; Jurica MS
J Nat Prod; 2021 May; 84(5):1681-1706. PubMed ID: 33974423
[TBL] [Abstract][Full Text] [Related]
18. Total synthesis of (+)-18-epi-latrunculol A: development of a synthetic route.
Williams BD; Smith AB
J Org Chem; 2014 Oct; 79(19):9284-96. PubMed ID: 25243951
[TBL] [Abstract][Full Text] [Related]
19. A Carbohydrate-Derived Splice Modulator.
Dhar S; La Clair JJ; León B; Hammons JC; Yu Z; Kashyap MK; Castro JE; Burkart MD
J Am Chem Soc; 2016 Apr; 138(15):5063-8. PubMed ID: 27058259
[TBL] [Abstract][Full Text] [Related]
20. Total synthesis of bryostatin 3.
Trost BM; Wang Y; Buckl AK; Huang Z; Nguyen MH; Kuzmina O
Science; 2020 May; 368(6494):1007-1011. PubMed ID: 32467391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
